Subsequently, we explored the effects of LOC285758 overexpression on biological abilities of AML progression and found that LOC285758 overexpression remarkably increased the viability and invasion of AML cells, suggesting that the regulatory effects of LOC285758 on AML were mediated through affecting the malignant abilities of AML cells. The gene discussed is MROCKI; the disease is acute myeloid leukemia.